Advertisement

Topics

Rubius raises $120M to advance re-engineered red blood cell therapies

10:56 EDT 22 Jun 2017 | SmartBrief

Rubius Therapeutics, which is developing a unique drug-discovery technique involving re-engineered red blood cells, has raise -More

Original Article: Rubius raises $120M to advance re-engineered red blood cell therapies

NEXT ARTICLE

More From BioPortfolio on "Rubius raises $120M to advance re-engineered red blood cell therapies"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...